109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
针刺治疗原发性痛经的长期疗效：系统评价与荟萃分析
Authors Shen X , Liu S , Chen H , Wang W , Fang J , Liu Z
Received 13 May 2025
Accepted for publication 1 October 2025
Published 11 October 2025 Volume 2025:18 Pages 5359—5376
DOI https://doi.org/10.2147/JPR.S540073
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Dr Houman Danesh
Xinyu Shen,1,2,* Sixing Liu,3,* He Chen,2 Wei Wang,1,2 Jiufei Fang,2 Zhishun Liu2
1Graduate College, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Department of Acupuncture, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China; 3School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhishun Liu, Department of Acupuncture, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, No. 5 Beixiange St., Xicheng District, Beijing, 100053, People’s Republic of China, Tel +8613651016313, Email zhishunjournal@163.com
Objective: Primary dysmenorrhea (PD) is a recurrent disease. The current treatments for PD often fail to provide long-lasting effects, underscoring the necessity for new treatment options that can offer durable benefits. Previous studies have indicated that the durable effect of acupuncture for PD remains uncertain. In this review, we aimed to evaluate the durable effect after completion of treatment.
Methods: Both English and Chinese literature were comprehensively retrieved from eight databases up to January 24, 2025. Two independent reviewers conducted screening and data extraction. The risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool. Meta-analysis was conducted where applicable. Pooled continuous data were expressed as mean differences (MD) and the safety outcomes were expressed through odds ratio (OR).
Results: Fourteen randomized controlled trials enrolled 970 patients met the inclusion and exclusion criteria. Acupuncture outperformed no intervention in reducing pain intensity measured by visual analogue scale (VAS) (MD − 47.80; 95% CI − 48.63 to − 46.97; p < 0.0001) and Short-Form McGill Pain Questionnaire (MD − 8.55; 95% CI − 11.46 to − 5.64; p < 0.0001), Cox Menstrual Symptom Scale (CMSS) duration score (MD − 18.24; 95% CI − 22.39 to − 14.09; p < 0.0001) and severity score (MD − 12.96; 95% CI − 16.41 to − 9.51; p < 0.0001) at 3 menstrual cycles post-treatment. Compared to non-steroidal anti-inflammatory drugs (NSAIDs), acupuncture showed superior pain relief measured by VAS (MD − 29.89; 95% CI − 37.63 to − 22.15; p < 0.0001), and symptom amelioration measured by CMSS (MD − 3.00; 95% CI − 5.92 to − 0.08; p = 0.0043) at 3 cycles post-treatment. Acupuncture also enhanced NSAIDs’ analgesic effect measured by VAS (MD − 19.95; 95% CI − 24.23 to − 15.66; p < 0.0001). However, acupuncture presented no superiority over sham acupuncture at 3 menstrual cycles post-treatment.
Conclusion: Acupuncture might provide durable post-treatment effects to primary dysmenorrhea patients up to three menstrual cycles, which was limited by high risk of bias and low certainty evidence.
Keywords: acupuncture, long term effects, meta-analysis, primary dysmenorrhea, systematic review
1Graduate College, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Department of Acupuncture, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China; 3School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhishun Liu, Department of Acupuncture, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, No. 5 Beixiange St., Xicheng District, Beijing, 100053, People’s Republic of China, Tel +8613651016313, Email zhishunjournal@163.com
Objective: Primary dysmenorrhea (PD) is a recurrent disease. The current treatments for PD often fail to provide long-lasting effects, underscoring the necessity for new treatment options that can offer durable benefits. Previous studies have indicated that the durable effect of acupuncture for PD remains uncertain. In this review, we aimed to evaluate the durable effect after completion of treatment.
Methods: Both English and Chinese literature were comprehensively retrieved from eight databases up to January 24, 2025. Two independent reviewers conducted screening and data extraction. The risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool. Meta-analysis was conducted where applicable. Pooled continuous data were expressed as mean differences (MD) and the safety outcomes were expressed through odds ratio (OR).
Results: Fourteen randomized controlled trials enrolled 970 patients met the inclusion and exclusion criteria. Acupuncture outperformed no intervention in reducing pain intensity measured by visual analogue scale (VAS) (MD − 47.80; 95% CI − 48.63 to − 46.97; p < 0.0001) and Short-Form McGill Pain Questionnaire (MD − 8.55; 95% CI − 11.46 to − 5.64; p < 0.0001), Cox Menstrual Symptom Scale (CMSS) duration score (MD − 18.24; 95% CI − 22.39 to − 14.09; p < 0.0001) and severity score (MD − 12.96; 95% CI − 16.41 to − 9.51; p < 0.0001) at 3 menstrual cycles post-treatment. Compared to non-steroidal anti-inflammatory drugs (NSAIDs), acupuncture showed superior pain relief measured by VAS (MD − 29.89; 95% CI − 37.63 to − 22.15; p < 0.0001), and symptom amelioration measured by CMSS (MD − 3.00; 95% CI − 5.92 to − 0.08; p = 0.0043) at 3 cycles post-treatment. Acupuncture also enhanced NSAIDs’ analgesic effect measured by VAS (MD − 19.95; 95% CI − 24.23 to − 15.66; p < 0.0001). However, acupuncture presented no superiority over sham acupuncture at 3 menstrual cycles post-treatment.
Conclusion: Acupuncture might provide durable post-treatment effects to primary dysmenorrhea patients up to three menstrual cycles, which was limited by high risk of bias and low certainty evidence.
Keywords: acupuncture, long term effects, meta-analysis, primary dysmenorrhea, systematic review